STAT+: AbbVie cuts ties with Google-backed longevity company, lays off scientists

AbbVie's termination of the long-standing partnership with Calico Life Sciences and the shift towards biologics and genetic medicines signifies a strategic move in drug development. This move, coupled with scientist layoffs, highlights the company's focus on innovative therapies and the potential impact on future R&D directions in the biotech/pharma industry.